¨A síndrome de POEMS é uma entidade clínica única definida pela presença concomitante de doença monoclonal de plasmócitos, polineuropatia periférica e outras manifestações paraneoplásicas tais como organomegalias, endocrinopatias, alterações cutâneas, papiledema, lesões osteoescleróticas e sobrecarga de volume extravascular. Para o diagnóstico da doença não é necessária a presença de todas as manifestações relacionadas e o reconhecimento precoce desta patologia é importante para reduzir a morbidade. A síndrome de POEMS também é conhecida como mieloma osteoesclerótico, síndrome de Crow-Fukase e síndrome de Takatsuki. A causa da síndrome de Poems é desconhecida. Para o diagnóstico da doença não é necessária a presença de todas as manifestações relacionadas; por outro lado, nenhuma prova laboratorial pode ser considerada como patognomônica isoladamente. Após uma revisão sistemática das três maiores séries publicadas sobre a síndrome de Poems reunindo um total de 226 pacientes, propuseram em 2003 a adoção de um sistema de critérios para o diagnóstico da síndrome de Poems baseado na freqüência e na relevância dos achados clínicos e laboratoriais que compõe esta patologia. O tratamento padrão da síndrome de POEMS ainda não está estabelecido e as principais opções são radioterapia, corticosteróides e agentes alquilantes, inclusive na forma de quimioterapia de altas doses com transplante autólogo de células-tronco hematopoiéticas.¨
■ An update on the diagnosis and management of the polyneuropathy of POEMS syndrome
Federica Cerri, Yuri Matteo Falzone, Nilo Riva, Angelo Quattrini
J Neurol. 2019; 266(1): 258–267
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343023/
■ POEMS syndrome: clinical update
Rachel Brown, Lionel Ginsberg
J Neurol. 2019; 266(1): 268–277
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6342878/
■ Síndrome de POEMS incompleto asociado a enfermedad de Castleman multicéntrica y amiloidosis
González de la Aleja, P et al
Anales Sis San Navarra 2017, vol 40 (3)
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1137-66272017000300475
■ POEMS syndrome and idiopathic portal hypertension: a possible association
Campos, Sara, Agostinho, Cláudia and Cipriano, Maria Augusta
Rev Esp Enferm Dig 2017, vol 109 (5): 393
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082017000500026&lng=es&nrm=iso
■ Endocrine manifestations in POEMS syndrome: a case report and literature review
Hui Li, Yumeng Huang, Yan Li, Baozhong Zheng, Jingqiu Cui, Ming Liu
BMC Endocr Disord. 2019; 19: 33
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431048/
■ Positron emission tomography-computed tomography in a case of POEMS syndrome
Jose Rafael Infante, Lucía García, Juan Ignacio Rayo et al
Indian J Nucl Med. 2019 Jan-Mar; 34(1): 66–6
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352633/
■ Frequent central nervous system, pachymeningeal and plexus MRI changes in POEMS syndrome
Oliver J. Ziff, Chandrashekar Hoskote, Stephen Keddie et al
J Neurol. 2019; 266(5): 1067–1072
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469836
■ High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the plasma cell disorder sub-committee of the chronic malignancy working party of the European Society for Blood & Marrow Transplantation
Gordon Cook, Simona Iacobelli, Anja van Biezen et al
Haematologica. 2017 Jan; 102(1): 160–16
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5210246/
■ Raised VEGF: high sensitivity and specificity in the diagnosis of POEMS syndrome
Morgane Pihan, Stephen Keddie, Shirley D’Sa, Andrew J. Church, Kwee L. Yong, Mary M. Reilly, Michael P. Lunn
Neurol Neuroimmunol Neuroinflamm. 2018 Sep; 5(5): e486
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117193/
■ POEMS syndrome: an update
Andrea Nozza
Mediterr J Hematol Infect Dis. 2017; 9(1): e2017051
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584767/
■ Nerve pathologic features differentiate POEMS syndrome from CIDP
Ezequiel A. Piccione, Janean Engelstad, Peter J. Dyck et al
Acta Neuropathol Commun. 2016; 4: 11
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088652/
■ Pulmonary morbidity improves after autologous stem cell transplantation in POEMS syndrome
Satish Chandrashekaran, Angela Dispenzieri, Stephen S. Cha, Cassie C. Kennedy
Respir Med. 2015 Jan; 109(1): 122–130
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758677/
■ An occult malignancyt behing a demyelinatingj disease: POEMS syndrome
Saberio Lo Presti, Prashanth Kanagarajah, Daniela Pirela, Diana Morlote, Mike Cusnir
J Investig Med High Impact Case Rep. 2016 Oct-Dec; 4(4): 2324709616673389
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072185/
■ Longitudinal bioimpedance assessments to evaluate hydration in POEMS syndrome
Amara Callistus Nwosu, Lauren Morris, Catriona Mayland et al
BMJ Support Palliat Care. 2016 Sep; 6(3): 369–372
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013159/
■ POEMS syndrome: complex factors contributing to a delayed diagnosis
Rebecca Caroline Robey, Craig Campus, Beverly Ringuette, Mark Shumate
BMJ Case Rep. 2015; 2015: bcr2015213123
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4680602/
■ Polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes (POEMS syndrome): a paraneoplastic syndrome
Sunil Kumar, Shruti Sharma
Oxf Med Case Reports. 2015 Mar; 2015(3): 237–240
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664845
■ POEMS syndrome, calciphylaxis and focal segmental glomerulosclerosis – VEGF as a possible link
Dorothee Heck, Miriam Mergen, Athina Ganner et al
BMC Neurol. 2014; 14: 210.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226878/
■ Outcomes of patients with POEMS syndrome treated initially with radiation
Michael S. Humeniuk, Morie A. Gertz, Martha Q. Lacy, et al
Blood. 2013 Jul 4; 122(1): 68–73
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067496/
■ POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, multiple myeloma and skin changes) with cranial vault plasmocytoma and the role of surgery in its management: a case report
Julio Plata Bello, Victor Garcia-Marin
J Med Case Rep. 2013; 7: 24
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016595/
■ Long-term therapy with lenalidomide in a patient with POEMS syndrome
Benjamin F. Chu, Arwa Shana’ah, Craig C. Hofmeister et al
Eur J Case Rep Intern Med. 2014; 1: 2014_000093
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326104/
■ Alcohol misuse link to POEMS syndrome in a patient
John Neary, Susan E. Goodwin, Lawrence B. Cohen, Manuela G. Neuman
Cancers (Basel) 2017 Oct; 9(10): 129
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664068/
■ How I treat POEMS syndrome
Angela Dispenzieri
Blood. 2012 Jun 14; 119(24): 5650–565
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425020/
■ Bone marrow histopathology in POEMS syndrome: a distinctive combination of plasma cell, lymphoid, and myeloid findigns in 87 patients
Linda N. Dao, Curtis A. Hanson, Angela Dispenzieri, et al
Blood. 2011 Jun 16; 117(24): 6438–644
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123015/
■ Bone marrow histopathology in POEMS syndrome: a distinctive combination of plasma cell, lymphoid, and myeloid findigns in 87 patients
Linda N. Dao, Curtis A. Hanson, Angela Dispenzieri, et al
■ Papiledema associado a síndrome de POEMS
Barnés, C et al
Arch Soc Esp oftalmol 2008, vol 83 (12): 709-711
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0365-66912008001200005&lng=es&nrm=iso
■ Síndrome de POEMS (mieloma osteoesclerótico).
Pinto Neto, Jorge V.
Rev. Bras. Hematol. Hemoter., Mar 2007, vol.29, no.1, p.98-10
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842007000100018&lng=en&nrm=iso
■Dr Paulo Fernando Leite
Cardiologia/Prevenção Cardiovascular
Estratificação de Risco Cardiovascular
Novo endereço:
Consultório: Rua Padre Rolim 815/sala 815
Tel: 33245518 (Consulta Particular/Unimed)
– Centro Médico Unimed BH/Contagem/Pedro I
Belo Horizonte/MG/Brasil
CRMMG: 7026
Email: pfleite1873@gmail.com